Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Adv Drug Deliv Rev ; 43(1): 65-92, 2000 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10967222

RESUMO

Bone morphogenetic proteins (BMPs) are multifunctional cytokines which are members of the Transforming Growth Factor-beta superfamily. They are the only signaling molecules which can singly induce de novo bone formation at orthotopic and heterotopic sites and their osteoinductive potency makes them clinically valuable as alternatives to bone graft. Several means of delivering BMPs to patients are undergoing evaluation including systemic administration, gene transfer and local matrix delivery vehicle implantation. The latter methodology is in advanced stages of development for application in humans in the treatment of selected spinal fusions, fracture repairs, craniomaxillofacial surgery and periodontal injury and disease. The BMPs are also widely distributed in non-skeletal tissues such as nerve, gastrointestinal tract, kidney, heart and lungs and they have a central role in vertebrate and non-vertebrate organogenesis. Initial studies indicate that the BMPs have neuro, cardio and reno-protective actions and it is likely that therapeutic indications for their use will extend well beyond skeletal disease and injury.


Assuntos
Proteínas Morfogenéticas Ósseas , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Animais , Doenças Ósseas/tratamento farmacológico , Proteínas Morfogenéticas Ósseas/administração & dosagem , Proteínas Morfogenéticas Ósseas/genética , Proteínas Morfogenéticas Ósseas/fisiologia , Proteínas Morfogenéticas Ósseas/uso terapêutico , Desenvolvimento Embrionário e Fetal/fisiologia , Fraturas Ósseas/tratamento farmacológico , Técnicas de Transferência de Genes , Terapia Genética , Humanos , Doenças Periodontais/tratamento farmacológico
2.
Int J Oral Maxillofac Implants ; 12(3): 403-11, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9197107

RESUMO

This study describes a novel animal model of the maxillary sinus floor augmentation procedure used to assess bone formation during 12 weeks in response to a recombinant human bone morphogenetic protein-2 (rhBMP-2)/absorbable collagen sponge (ACS) sinus implant. A buffer-ACS implant was used as a control. Animal response was monitored using computerized tomography and physical, hematologic, gross pathologic, and histologic evaluations. The rhBMP-2/ACS implants maintained a relatively constant size postsurgery and showed a time-dependent increase in mineralization. The buffer/ACS control implants failed to mineralize and were resorbed by 4 weeks. The model served effectively and without complication. Results indicate rhBMP-2/ACS implants deserve consideration as alternatives to traditional grafting procedures.


Assuntos
Proteínas Morfogenéticas Ósseas/uso terapêutico , Colágeno/uso terapêutico , Modelos Animais de Doenças , Seio Maxilar/cirurgia , Próteses e Implantes , Fator de Crescimento Transformador beta/uso terapêutico , Absorção , Animais , Proteína Morfogenética Óssea 2 , Transplante Ósseo , Soluções Tampão , Calcificação Fisiológica/efeitos dos fármacos , Feminino , Cabras , Humanos , Maxila/diagnóstico por imagem , Maxila/efeitos dos fármacos , Maxila/patologia , Maxila/cirurgia , Seio Maxilar/diagnóstico por imagem , Seio Maxilar/efeitos dos fármacos , Seio Maxilar/patologia , Osteogênese/efeitos dos fármacos , Proteínas Recombinantes , Tomografia Computadorizada por Raios X
3.
J Vet Dent ; 13(4): 145-8, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9520790

RESUMO

A 22-year-old thoroughbred gelding was presented for evaluation and treatment of chronic dental disease. The horse had a history of quidding and abnormal bite behavior. Intraoral examination revealed signs of chronic generalized gingival inflammation and severe dental caries affecting the maxillary and mandibular incisor teeth. Treatment was provided on two separate visits over an interval of four months. The first visit consisted of the surgical extraction of three unrestorable incisor teeth and restoration of six carious maxillary incisor teeth. The second visit consisted of conventional endodontic therapy on the remaining mandibular incisor teeth and the surgical removal of a chronic suppurative osteomyelitic lesion. Immediate and long term improvements in eating habits were noted. Three month follow-up examinations following completion of treatment have shown the teeth to be in functional position, the restorations intact, and the surgical site well healed.


Assuntos
Doenças dos Cavalos/terapia , Doenças Mandibulares/veterinária , Osteomielite/veterinária , Tratamento do Canal Radicular/veterinária , Animais , Doença Crônica , Terapia Combinada , Cárie Dentária/terapia , Cárie Dentária/veterinária , Seguimentos , Gengivite/terapia , Gengivite/veterinária , Cavalos , Masculino , Mandíbula , Doenças Mandibulares/cirurgia , Maxila , Osteomielite/cirurgia , Extração Dentária/veterinária
4.
Vet Surg ; 24(5): 408-19, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8585149

RESUMO

Bone morphogenetic proteins (BMPs) are differentiative factors whose principal function is to induce transformation of undifferentiated mesenchymal cells into chondroblasts and osteoblasts in a dose-dependent manner. Bone morphogenetic proteins have been isolated postnatally in mammals from bone matrix, periosteal cells, mesenchymal cells of marrow stroma, tooth analagen, and cells of osteosarcoma and chondrosarcoma. Distribution in additional embryonic tissues implies a broader organogenic function. Bone morphogenetic proteins are the only differentiative factors able to singularly induce de novo bone formation in vitro and in vivo. Recombinant DNA technology allows their production in large and highly purified quantities. The BMPs' osteoinductive ability has been shown with a variety of carriers including collagens and polymers at heterotopic and orthotopic sites in a wide range of species. They are presently being readied for clinical use as alternatives to bone grafts. Other potential applications include use as pulp capping agents, promoters of implant osteointegration and soft tissue reunion with bone, treatments for nonadaptive bone disease, and implants for use with mitotically expanded skeletal stem cell populations. Errors in the genetic coding of BMPs may manifest as clinical disease entities.


Assuntos
Doenças Ósseas/veterinária , Osso e Ossos/lesões , Substâncias de Crescimento/uso terapêutico , Proteínas/uso terapêutico , Cicatrização/fisiologia , Animais , Doenças Ósseas/diagnóstico por imagem , Doenças Ósseas/tratamento farmacológico , Proteínas Morfogenéticas Ósseas , Osso e Ossos/diagnóstico por imagem , Osso e Ossos/fisiologia , Substâncias de Crescimento/genética , Substâncias de Crescimento/metabolismo , Proteínas/genética , Proteínas/metabolismo , Radiografia , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/uso terapêutico
5.
Vet Surg ; 30(4): 366-73, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11443598

RESUMO

OBJECTIVES: To determine for equine hooves the normal resident aerobic bacterial population and the efficacy of 2 methods of disinfection. Study Design-Measurement of total bacterial, gram-positive bacterial, and gram-negative bacterial surface populations from the frog, sole, and hoof wall after each step of 2 different preoperative surgical disinfection techniques. ANIMALS: Six adult horses. METHODS: Hoof wall, sole, and frog samples were collected for quantitative bacteriology before, during, and after 2 multistep antiseptic preparation techniques: Method A-6-minute scrub with povidone-iodine soap, followed by 24-hour submersion in povidone-iodine solution-soaked cotton; and Method B-initial removal of superficial layer of hoof capsule before completing Method A disinfection procedures. RESULTS: Removal of the superficial hoof layer, application of the povidone iodine scrub, and completion of the povidone-iodine soak all significantly (P < .0008) decreased total bacterial numbers. Method B had significantly lower bacterial counts than method A at each consecutive step. Final total bacterial counts remained greater than 10(5) bacteria per gram of tissue regardless of preparation method. CONCLUSIONS: The hoof surface hosts a broad spectrum of aerobic gram-positive and -negative bacteria, many of which are potential pathogens. Bacterial numbers can be significantly reduced by removal of the superficial hoof surface, by application of a povidone-iodine scrub, and by use of a 24-hour povidone-iodine soak. However, bacterial populations >10(5) g per tissue persist after these disinfection procedures. CLINICAL RELEVANCE: Regardless of the preparation methods used in this study, bacterial populations capable of inducing wound infection remain on the hoof capsule.


Assuntos
Anti-Infecciosos Locais/farmacologia , Desinfecção/métodos , Casco e Garras/microbiologia , Cavalos/microbiologia , Cavalos/cirurgia , Povidona-Iodo/farmacologia , Cuidados Pré-Operatórios/veterinária , Animais , Anti-Infecciosos Locais/administração & dosagem , Contagem de Colônia Microbiana , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/efeitos dos fármacos , Bactérias Gram-Positivas/isolamento & purificação , Povidona-Iodo/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA